LAIX Stock Forecast, Price & News

Wall Street analysts have given LAIX a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LAIX wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

LAIX is scheduled to release its next quarterly earnings announcement on Wednesday, August 25th 2021.
View our earnings forecast for LAIX.

LAIX Inc. (NYSE:LAIX) issued its earnings results on Wednesday, May, 26th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.59) by $0.65. The company had revenue of $30.30 million for the quarter.
View LAIX's earnings history.

LAIX's stock was trading at $4.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, LAIX stock has decreased by 80.1% and is now trading at $0.97.
View which stocks have been most impacted by COVID-19.

LAIX issued an update on its second quarter 2021 earnings guidance on Tuesday, June, 22nd. The company provided earnings per share (EPS) guidance of $- for the period. The company issued revenue guidance of $24.42 million-27.47 million.

Some companies that are related to LAIX include Lincoln Educational Services (LINC), Aspen Group (ASPU), Lixiang Education (LXEH), Tarena International (TEDU), Boxlight (BOXL), First High-School Education Group (FHS), Sunlands Technology Group (STG), ATA Creativity Global (AACG), RYB Education (RYB), OneSmart International Education Group (ONE), Zovio (ZVO), RISE Education Cayman (REDU), China Online Education Group (COE), Puxin (NEW) and Meten EdtechX Education Group (METX).
View all of LAIX's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other LAIX investors own include Gilead Sciences (GILD), AbbVie (ABBV), International Business Machines (IBM), Pfizer (PFE), Alnylam Pharmaceuticals (ALNY), Algonquin Power & Utilities (AQN), Arcturus Therapeutics (ARCT), Broadcom (AVGO), Alteryx (AYX) and BCE (BCE).

(LAIX) raised $72 million in an initial public offering on Thursday, September 27th 2018. The company issued 5,800,000 shares at $11.50-$13.50 per share. Morgan Stanley and Goldman Sachs (Asia) served as the underwriters for the IPO.

LAIX trades on the New York Stock Exchange (NYSE) under the ticker symbol "LAIX."

LAIX's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Davy Global Fund Management Ltd (0.39%).

LAIX stock was bought by a variety of institutional investors in the last quarter, including Davy Global Fund Management Ltd.

Shares of LAIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of LAIX stock can currently be purchased for approximately $0.97.

LAIX has a market capitalization of $48.11 million and generates $149.06 million in revenue each year. The company earns $-60,510,000.00 in net income (profit) each year or ($1.13) on an earnings per share basis.

LAIX employs 1,684 workers across the globe.

The official website for LAIX is ir.laix.com.

LAIX is headquartered at 3/F. BUILDING B NO. 1687 CHANGYANG ROAD YANGPU DISTRICT, SHANGHAI F4, 200090.

LAIX's mailing address is 3/F. BUILDING B NO. 1687 CHANGYANG ROAD YANGPU DISTRICT, SHANGHAI F4, 200090. The company can be reached via phone at 86-21-3511-7188 or via email at [email protected]